Back to search

Article

Dihydroartemisinin Sensitizes Esophageal Squamous Cell Carcinoma to Cisplatin by Inhibiting Sonic Hedgehog Signaling

2020-07-06

Abstract excerpt

<h4>Background: </h4> Platinum-based regimens have been routinely used in the clinical treatment of patients with esophageal squamous cell carcinoma (ESCC). However, administration of these drugs is frequently accompanied by drug resistance. Revealing the underlying mechanisms of the drug resistance and developing agents that enhance the sensitivity to platinum may provide new therapeutic strategies for the patien...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3d43aaad-b460-50d0-93be-f3c3887de04e
DOI
10.21203/rs.3.rs-39625/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Dihydroartemisinin Sensitizes Esophageal Squamous Cell Carcinoma to Cisplatin by Inhibiting Sonic Hedgehog SignalingDOI 10.21203/rs.3.rs-39625/v1
Select a neighboring publication to make it the new centre.